Intuitive Surgical
Open
$410.57
Prev. Close
$410.95
High
$411.00
Low
$410.24
Market Snapshot
$145.98B
49.0
6.54
$8.35B
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Recently from Cashu
Intuitive Surgical Appoints Taylor Patton as Chief Commercial and Marketing Officer Amid Growth Strategies
In recent developments, Intuitive Surgical Inc (Ticker: ISRG) appoints Taylor Patton as its new Chief Commercial and Marketing Officer. The leadership change is set to take effect from July 1, reflect…
Intuitive Surgical Enhances da Vinci 5 Platform with Key Upgrades and Strategic Leadership Changes
Intuitive Surgical (Ticker: ISRG) is actively enhancing its da Vinci 5 robotic surgery platform, focusing on more than 100 vital upgrades designed to improve surgical efficiency. A key part of this up…
Intuitive Surgical Prioritizes Patient Safety by Removing Risky Staplers Following FDA Guidance
Intuitive Surgical Takes Proactive Measures in Patient Safety Amidst FDA Guidance Intuitive Surgical, a leader in robotic-assisted surgical systems, has promptly notified customers about the removal o…
Intuitive Surgical Takes Action on Stapler Safety to Ensure Patient Protection and Compliance
Intuitive Surgical Proactively Addresses Stapler Safety Concerns Intuitive Surgical, a leader in robotic-assisted surgical systems, issues a vital notification to its customers regarding the immediate…